Chester County News and Community Website
DUBLIN, IRELAND, AND MALVERN, PA — Pharmaceutical leaders Mallinckrodt plc and Endo, Inc. (OTCQX: NDOI) have entered an agreement to merge, creating a global, diversified company poised to deliver enhanced patient …
Mallinckrodt and Endo Announce Merger to Build Diversified Pharmaceuticals Powerhouse Read More MALVERN, PA — Endo, Inc. (OTCQX: NDOI) revealed new insights from a post hoc data analysis of its Phase 3 clinical trial of XIAFLEX® (collagenase clostridium histolyticum, or CCH) for …
Endo, Inc. Shares Positive Data on XIAFLEX Treatment for Peyronie’s Disease Read More MALVERN, PA — Endo, Inc. (OTCQX: NDOI) has announced a definitive agreement to divest its International Pharmaceuticals business, operated primarily through Canada-based Paladin Pharma Inc., to Knight Therapeutics Inc. The deal, …
Endo, Inc. to Sell International Pharmaceuticals Business to Knight Therapeutics Read More MALVERN, PA — Endo, Inc. (OTCQX: NDOI) has announced plans to release its fourth quarter and full-year 2024 financial results on March 11, 2025, before the market opens. The company will …
Endo, Inc. to Announce 2024 Financial Results on March 11, 2025 Read More MALVERN, PA — Endo, Inc. (OTCQX: NDOI) has unveiled its new branded television commercial, “Steve’s Journey,” as part of a broader effort to educate the public about Dupuytren’s contracture, a progressive …
Endo, Inc. Launches New “Steve’s Journey” Campaign to Raise Awareness About Dupuytren’s Contracture Read More MALVERN, PA — Endo, Inc. (OTCQX: NDOI) has launched its new television commercial and disease awareness campaign, “I Got Somebody,” to encourage men experiencing symptoms of Peyronie’s disease (PD) to take …
Endo, Inc. Launches “I Got Somebody” Campaign to Raise Awareness About Peyronie’s Disease Read More MALVERN, PA — Endo, Inc. (OTCQX: NDOI) has introduced a new tool to support men dealing with Peyronie’s disease (PD). The self-assessment screening app, designed to help individuals identify and …
ICYMI: New App Helps Men Address Peyronie’s Disease Read More MALVERN, PA — Endo, Inc. (OTCQX: NDOI) has introduced a free self-assessment app designed to help men manage Peyronie’s disease (PD), a condition involving penile curvature that can be both …
New App Aims to Empower Men with Peyronie’s Disease Read More MALVERN, PA — Endo, Inc. (OTCQX: NDOI) has announced the start of shipments for its doxycycline for injection, USP 100 mg/vial, a generic alternative to DOXY 100™. This marks a significant …
Endo Inc. Launches Generic Doxycycline for Injection Read More MALVERN, PA — Endo, Inc. (OTCQX: NDOI) has secured U.S. Food and Drug Administration (FDA) approval for the commercial production of VASOSTRICT® (vasopressin injection, USP) at its newly constructed aseptic manufacturing …
Endo Receives FDA Approval for New Sterile Injectable Facility in India Read More